AI-generated summary
This narrative review describes a systematic approach to diagnosing and treating sleep disorders in people with neurocognitive disorders. The authors recommend mainly nonpharmacological strategies, such as CPAP for moderate to severe sleep apnea, cognitive-behavioral therapy for insomnia, and light exposure, while noting that pharmacological indications remain limited. They call for further randomized trials to evaluate these treatments.
- Who or what was studied
- Patients with neurocognitive disorders, including Alzheimer's disease and alpha-synucleinopathies such as Parkinson's disease and Lewy body dementia
- Limits stated in the abstract
- The paper is a narrative review, and the authors state that pharmacological indications remain limited and that further randomized clinical trials are needed.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Insomnia, Dose, Bright light therapy, Dementia. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.